{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} IBD LIVE Case Series--Case 4: Worms in IBD: Friend or Foe

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

IBD is also pleased to inform our readers that this CME activity is now eligible for the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) credit based on the most recent collaboration between the ABIM and the ACCME. In order to receive ABIM MOC for this CME activity each participant will need to make sure that the information on their profile for the CME platform (where his activity is located) is updated with 1) Their DOB-Month and Day only and 2) That they have selected that they are board certifed in the profile via the ABIM. When this selection is made they will be required to enter their ABIM number. (Which is assigned via the ABIM). Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. The Lippincott Continuing Medical Education Institute will submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Define the "hygiene hypothesis" of autoimmune diseases.
  2. Understand the reasoning behind Trichuris suis ova (TSO) therapy for inflammatory bowel disease.
  3. Know the key findings of trials using TSO in patients with Crohn's disease and ulcerative colitis.
  4. Be aware of the potential risks regarding helminth therapy.
  5. Be aware of the scope of complementary and alternative medicine (CAM) use in the United States, particularly among individuals with inflammatory bowel disease.

Disclosures

All authors and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.

Price: FREE

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: IBD0616
Published: June 2016
Expires: 1/1/2026
Sources: Inflammatory Bowel Diseases
Required Passing Score: 7/9 (77%)
Authors: Abhishek Gulati, MD, Kofi Clarke, MD, Julia B. Greer, MD, MPH, David G. Binion, MD, Myron H. Brand, MD, Francis A. Farraye, MD, MSc, Raymond K. Cross, MD, MS, Leonard Baidoo, MD, Wolfgang H. Schraut, MD, Douglas J. Hartman, MD, and Miguel D. Regueiro, MD
Categories: Gastrointestinal
Specialties: Gastroenterology
Topics: Inflammatory Bowel Disease (IBD) , Worms